Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Insomnia Market Value Growth And Long-Term Outlook
The insomnia market has experienced significant growth in recent years. It is projected to expand from $5.22 billion in 2025 to $5.52 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.7%. The historical period’s growth can be attributed to the rising prevalence of sleep disorders, increased stress and lifestyle changes, widespread use of benzodiazepines and sedatives, growing diagnosis rates of insomnia, and the expansion of sleep clinics and specialists.
The insomnia market size is anticipated to experience substantial expansion over the coming years, projected to reach $7.03 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.3%. This projected growth during the forecast period stems from factors such as the increasing uptake of digital therapeutics, a rising demand for safer and more enduring insomnia treatments, an expanding geriatric population, heightened mental health awareness, and wider accessibility to online and retail pharmacies. Key trends identified for this period encompass the growing preference for non-pharmacological insomnia interventions, an increase in the application of cognitive behavioral therapy for insomnia, a greater inclination towards personalized sleep management, the broader utilization of combination therapy methods, and an escalating recognition of chronic insomnia as a legitimate medical condition.
Get A Free Sample Report With In-Depth Market Insights:
Insomnia Market Growth Momentum: What Factors Are Shaping Demand?
The rising occurrence of chronic diseases is anticipated to fuel the expansion of the insomnia market in the future. Chronic disease is defined as an ailment persisting for at least three months, with the potential to worsen over time. Individuals affected by long-term health problems, such as cardiovascular disorders, diabetes, and chronic pain conditions, frequently encounter insomnia or other sleep disturbances as a co-occurring condition. This escalating prevalence generates a need for effective treatments and management approaches for insomnia, thereby stimulating the market for products and services aimed at tackling sleep disorders. For instance, in April 2025, according to the Centers for Disease Control and Prevention, a US-based federal public health agency, 76.4% of US adults, representing about 194 million people, reported having one or more chronic conditions in 2023, with prevalence at 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Consequently, the expanding occurrence of chronic diseases is propelling the growth of the insomnia market.
Insomnia Market Segment Landscape: Which Areas Lead Development?
The insomnia market covered in this report is segmented –
1) By Therapy Type: Non-Pharmacological Therapy, Pharmacological Therapy
2) By Drug Class: Anti-Depressants, Melatonin Antagonist, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, Other Drug Classes
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Non-Pharmacological Therapy: Cognitive Behavioral Therapy For Insomnia (CBT-I), Sleep Hygiene Education, Relaxation Techniques, Stimulus Control Therapy, Sleep Restriction Therapy
2) By Pharmacological Therapy: Prescription Medications, Over-The-Counter, Herbal Supplements
Insomnia Market Trends Redefining Industry Growth
Major companies operating in the insomnia market are actively developing new products, including zaleplon-based insomnia drugs, to gain a competitive advantage. Zaleplon is a non-benzodiazepine sedative-hypnotic medication employed for the short-term management of insomnia. For instance, in April 2023, Bukwang Pharm Co Ltd., a South Korea-based pharmaceutical company, launched Zaledeep Cap., representing the first insomnia treatment in South Korea to utilize zaleplon as its primary ingredient. Zaleplon, an FDA-approved non-benzodiazepine drug for treating insomnia, is characterized by its rapid onset of action, short half-life, and minimal impact on daily activities. Given the increasing prevalence of insomnia cases in modern society, the introduction of Zaledeep Cap. is expected to provide a novel and effective treatment solution, aiming to improve sleep quality and overall well-being for individuals experiencing insomnia.
Insomnia Market Industry Leaders And Competitive Landscape
Major companies operating in the insomnia market are Pfizer Inc., Merck & Co Inc., Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Viatris Inc., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Eisai Co.Ltd., UCLA Health Insomnia Clinic, Jazz Pharmaceuticals PLC, Aurobindo Pharma Limited, Purdue Pharma LP, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Zydus Lifesciences Limited, Lupin Limited, Mallinckrodt Pharmaceuticals Plc., Fisher & Paykel Healthcare Corporation Limited, ResMed Inc., Sunovion Pharmaceuticals Inc., Casper Sleep Inc., Biocodex Inc., Vanda Pharmaceuticals Inc., Pernix Therapeutics Holdings Inc., SleepScore Labs, Alpha-Stim, Neurim Pharmaceuticals Ltd., NightWare Inc.
View The Full Insomnia Market Report:
Insomnia Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the insomnia market in 2025. The regions covered in the insomnia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Leave a Reply